QL2401

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL2401, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults [Phase 1]